Comparison of magnetic guidewire navigation in percutaneous coronary intervention (MPCI) vs. conventional percutaneous coronary intervention (CPCI) for the treatment of acute myocardial infarction.
Introduction
Magnetic navigation uses two computer-controlled magnets to produce an adjustable magnetic field to precisely and actively deflect a tip-mounted magnet on an angioplasty wire. This gives the fundamentally new ability of active control of the angle of approach of the 'front-end' of the wire. The precise steering of a wire has a number of potential advantages in percutaneous coronary intervention (PCI). It could enhance wire passage by maintaining a coaxial vessel orientation, by steering away from eccentric lesions or thrombus, by enabling more accurate sidebranch cannulation, or by reducing problems inherent with conventional wires such as wire entanglement in two wire procedures.
Percutaneous coronary intervention using magnetic navigation is feasible in a variety of lesion types 1 -8 and shows an advantage in distal lesions. 7 However, although use in primary PCI has been described, 8 the potential benefit remains unknown. It is conceivable that magnetic navigation may give an advantage in both the straightforward cases 6 and particularly in complex cases. 7 Timely reperfusion of patients undergoing primary PCI is a priority. 9 -13 However, magnetic guidewire navigation PCI (MPCI) requires both preparation and familiarity for efficient use and therefore it remains unclear as to whether the burden of the additional preparation and performance of this wire technique is detrimental.
We examined the feasibility of MPCI vs. conventional guidewire navigation PCI (CPCI) by comparing patients having MPCI for acute myocardial infarction with historical control patients who had undergone CPCI as part of a previous trial in primary PCI, the PASSION trial. 14, 15 
Methods

Selection of patients and age-matched controls
Between November 2006 and July 2007, 240 consecutive patients underwent primary PCI in our centre. From this patient group, 65 sequential patients presenting to MPCI operators underwent primary MPCI. The patients who underwent MPCI were all within the age of 18 -80 and had not had thrombolysis. There were no patients with a contraindication to aspirin or clopidogrel, cardiogenic shock requiring support, known intracranial disease or life expectancy less than 6 months. Patients who were intubated and ventilated did not have their procedure in the magnetic navigation room due to restricted space. There were no specific contraindications to MPCI in this series, but care was taken to check that there were no previously implanted ferrous devices. None of the patients in the MPCI group had pacemakers or implantable cardiac defibrillators. Other nonprimary PCI patients with implanted electronic devices have undergone MPCI procedures and should be monitored during the procedure and the devices checked afterwards.
The baseline characteristics, angiographic characteristics, and procedural outcomes of these patients were compared with a historical control group, which consisted of the cohort of patients that had been treated by primary CPCI for acute myocardial infarction as part of the PASSION trial. 14, 15 Exclusion criteria for the PASSION group have been previously described. 14 Patients were excluded if they had received thrombolytic therapy, the infarction was caused by in-stent thrombosis or restenosis, there was a contraindication to aspirin, clopidogrel, or both, patients were participating in another clinical trial, cardiogenic shock was evident before randomization, the neurological outcome after resuscitation was uncertain, they had undergone intubation, ventilation, or both, there was known intracranial disease, or the estimated life expectancy was less than 6 months. In summary, differences between the two groups were that MPCI procedures were only performed if one of the two trained operators were present or had on-call duty and the magnetic room was available. In addition, patients in the PASSION trial were only randomized after successful wire passage (and therefore with enough flow to assess vessel size) and that complex anatomy such as in-stent restenosis or stent thrombosis were contraindicated, while the magnetic procedure registry includes all patients who had their procedure in the MPCI room and complex anatomy was not excluded.
All patients gave informed consent to the proposed procedure. Thrombectomy was performed at the discretion of the operator. Angiography of the other coronary vessels was performed routinely in all cases in both groups.
The magnetic navigation system
The Niobe w II magnetic navigation system (MNS; Stereotaxis, St Louis, MO, USA) has been described in detail previously. 1, 3 The system comprises two external magnets with the controls and software for applying and changing the magnetic field ( Figure 1) . A 15 -20 cm spherical volume with a uniform magnetic field is produced that is centred on the heart of the patient and can be reliably and reproducibly directed in 3608 in all planes. A number of methods are available to alter the direction of the magnetic field. The 2D clockface is displayed in the plane of the fluoroscopy screen and so 3608 can be selected in this plane, and two icons at the bottom corners of this window direct the field into (denoted by a circled 'X'), and out of (denoted by a circled '.'), the plane of fluoroscopy giving the operator 3D control ( Figure 2 ). Selection by presets uses the average directions of vessel segments taken from 50 MSCT scans and thus automatically incorporates 3D directions. The use of a 3D reconstruction from patient images is essentially an individualized set of presets. The selection of a direction by the operator leads to movement of the two external magnets to change the magnetic field vector in three dimensions that will actively deflect the magnetic wire tip and result in reproducible steering. The operator interfaces with the system via the Navigant TM Work Station software. Navigation in MPCI cases was performed using preset and clockface navigation for two reasons. First, it was felt to be suitable in terms of practicality and feasibility in order to reach and cross most/all lesions as it can be used as soon as the magnets are in position rather than waiting for the production of a reconstruction that can be timeconsuming. Secondly, the 3D reconstruction can only be made properly with a patent vessel so this excluded a significant proportion of cases.
The use of the system requires the patient to be placed at the fluoroscopic and magnetic isocentre. This is performed directly on engagement of the coronary artery by fluoroscopy in a lateral position for the correct vertical table height and then a further angulation such as LAO 458 to obtain a suitable horizontal position. Angiographic films can then be taken to identify the site and anatomy of the occlusion. The magnets are then brought in. These manoeuvres were routinely performed as the wire, thrombectomy device, indeflator, and other equipment were being unpacked and prepared. The procedural time for MPCI includes all the time needed for system preparation such as isocentring and adjusting patient position (see Discussion). The angioplasty wires for magnetic procedures were the standard magnetically enabled wires supplied by the company.
Magnetically enabled wires
A series of magnetically enabled disposable guide wires, which are custom designed for use with the MNS, are available in a variety of sizes and a range of stiffness. For this comparison, the Titan TM Figure 1 The Niobe w Magnetic Navigation System in position for PCI. M indicates magnets in tilt position for better lateral movement of the image intensifier. T indicates touch screen interface to give real-time instruction to the MNS. S indicates in-lab main screen monitor, C indicates the controls for magnet deployment.
guidewires were used ( Figure 3 ). They are specifically designed to be more flexible and steerable for magnetic navigation. They are 180 cm moderate support, hydrophilic coated wires with a diameter of 0.014 in/0.36 mm having a flexible 2 cm distal coiled tip at the end of which is a gold cup attached to a 2 or 3 mm neodynium magnet.
Percutaneous coronary intervention procedure
The inner diameter of all 6 F guides was 0.70 in. The choice of guiding catheter and equipment was left entirely to the discretion of the operator and followed routine practice as did the use of drug-eluting stents, bare metal stents, and the use of glycoprotein IIb/IIIa receptor Figure 2 The screen of the Navigant TM workstation (2.11 version), the panel (P) shows virtual coronary tree of the preset navigation with the list of preset vectors (V) seen above. The panel (C) shows the 2D clockface with two icons in the bottom corner that allow direction of the vector into (denoted by circled 'X'), or out of (denoted by circled '.'), the plane of fluoroscopy. antagonists. There were no restrictions on the operators' choice of conventional wire or routine practice. Routine procedure in our institution is to take at least two orthogonal planes after the intracoronary administration of 100 -200 mg of nitroglycerine and to repeat these at the end of the procedure. There were no additional views in the PASSION trial patients that were only for study purposes. Thrombectomy was performed at the discretion of the operator. Angiography of the other coronary vessels was performed routinely in all cases in both groups.
The interventional staff includes five senior operators; CPCI procedures were performed by all five operators, whereas MPCI procedures were performed by two of the five operators.
Aspirin, 500 mg i.v. and clopidogrel, 600 mg p.o. were given to all patients. Unfractionated heparin, 10 000 IU/kg, was given as an intravenous bolus at the beginning of the procedure. Routine access was via the radial approach.
Angiographic variables
All angiograms were stored in a computer database and analysed off-line by an independent observer, using CAAS 2003 Camtronics (Philips Medical Systems, Eindhoven, The Netherlands).
Definition of endpoints
The major endpoint was the amount of contrast media used to complete the procedure. Secondary endpoints were fluoroscopy time, total procedural time, number of wires, number of balloons and stents, and major adverse cardiac events. The aim was to evaluate procedural outcome in both groups in terms of contrast media use, technical success, procedural and fluoroscopy duration, and material consumption. Technical success was defined as an intraluminal wire position distal to the stenoses. Procedural success was defined as (i) TIMI Grade III flow, 16 (ii) ,30% residual stenosis, and (iii) absence of clinical events during the admission (death, acute stent thrombosis, re-infarction before discharge, emergency coronary artery bypass grafting, and stroke). Procedural duration was measured from the time of sheath insertion until the removal of the guiding catheter at the end of the procedure (and included all the time needed for system preparation such as isocentring and adjusting patient position, see Discussion). Fluoroscopy times were automatically recorded by the Poly Diagnost (C2) Digital Cardiac Imaging System (Philips). Additional endpoints were the length and diameter of stents per patient. Distal embolization was specifically noted in the MPCI patients.
Statistical analysis
For comparison of continuous variables between the two groups, the unpaired two-tailed Student's t-test was used or, for skewed data, such as contrast media, the Wilcoxon's rank sum test, and these were expressed as the median and inter-quartile range. Comparison of categorical variables between the two groups was performed using the x 2 test, or in cases of a minimum expected count less than 5, the Fisher exact test, and these were expressed as the number and/or percentage. A two-sided P-value less than 0.05 was considered statistically significant. Statistical tests were carried out with the SPSS 14.0 statistical software package (Chicago, IL, USA). All continuous endpoints were dichotomized according to the worst tertile vs. the other two tertiles. As the number of MPCI patients was restricted, a propensity score was used and included in a logistic model to adjust MPCI vs. CPCI for contrast media consumption, fluoroscopy, etc.
Results
Baseline demographics
Primary MPCI in 65 consecutive patients was compared with primary CPCI of 405 historical control patients. Baseline clinical characteristics were similar in both groups, although there were fewer patients with previous coronary artery bypass grafting (CABG) and hypertension in the CPCI group compared with the MPCI group ( Table 1) . There were fewer patents with diabetes in the MPCI group. Baseline angiographic variables showed that the reference vessel diameter in the MPCI group was marginally, but statistically, smaller than the CPCI group and that there was a statistically significant predominance of ACC/AHA type C lesions in the MPCI group ( Table 2) . Lesions had a similar distribution in the three coronary arteries ( Table 3) . Overall technical and procedural success was high (95.4% MPCI vs. 98.0% CPCI) in both groups ( Table 4) Presented as percentages (within parentheses) or in other cases means + SD. n, number; CAD, coronary artery disease; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting.
Comparison of magnetically navigated and conventional PCI in acute MI (Table 4) . Multivariate analysis showed that there was significantly less contrast media use in the MPCI compared with the CPCI group, OR ¼ 0.41 (0.21-0.81) ( Table 5) . Fluoroscopy times were significantly reduced for MPCI compared with CPCI OR ¼ 0.42 (0.20-0.79) ( Table 5) . Distal embolization was seen in 7.7% (5/65) of patients in the MPCI, unfortunately that data were not available from the PASSION trial, but this figure is below the 15.2% incidence quoted in the literature. 17 
Discussion
This comparison of magnetic navigation with conventional wire technique in patients undergoing primary PCI suggests that MPCI procedures can be performed as effectively, as defined by contrast media use, procedural time, fluoroscopy time, and success rate, as CPCI. Indeed, the results show equivalent procedural performance with significant reductions in the contrast media use and fluoroscopy time. Previously published data from this registry showed that magnetic navigation in simple lesions significantly benefited only one of these three parameters (with a small reduction in median contrast media use and non-significant trends in fluoroscopy and procedural times in simple lesions), 6 whereas all three were significantly improved in complex lesions. 7 In this comparison, two of the three parameters were significantly improved and one was not significantly improved, suggesting an intermediate position for this subgroup However, these comparisons are hypothesis-generating and there may be other confounding factors, thus to reach a definitive conclusion, randomized studies are required. The rapid restoration of full TIMI 3 flow is crucial in primary PCI 9 with strong evidence that swift restoration of flow in the obstructed infarct artery is a key determinant of short-and longterm outcome. 10 -14 However, reported rates of achieving TIMI 3 flow, range from only 70 to 90% 10 -14 and this leaves a proportion of procedures where improvement is possible. Potentially this lack of success could be due to the more complex anatomy where the MNS would help. This new technique gives the operator new and definable capabilities. Active tip adjustment can change the angle of approach of the tip as required, in order to maintain the tip coaxially through normal vessel, or in order to steer around bends or into sidebranches. Three dimensional directability is obtained by using the clockface (automatically displayed in the plane of the 2D image), by using presets (average directions of vessel segments), or, in cases with more complex anatomy, by using a 3D reconstruction from patient images.
Furthermore, primary PCI using the MNS could conceivably give benefits such as minimizing wire-tip rotation thus reducing wire entwinement, or allowing circumnavigation around friable thrombotic lesions, a known predictor of distal embolization and no-reflow phenomena. 18 In this comparison, embolization was recorded only in the MPCI group (and not in the PASSION group), but the rate seen was lower than reported in the literature. 
Presented are the absolute numbers of lesions with percentages (within parentheses). SVG, saphenous vein graft.
In this comparison, an increased use of wires was seen. The cases where multiple wires were used have been reviewed and a number of reasons appear to be related to this. First, there were more bifurcational lesions in the MPCI group and a greater tendency to choose a second wire (Table 4) . Second, there was a more complex case mix in the MPCI group that included, for example, in stent thrombosis. In two of the five in-stent thrombosis cases, multiple wires were used. Third, the stainless steel core of the Titan wire has a poorer memory (or the tendency to return to its previous shape), than conventional wires and a replacement was needed in three bifurcation lesions. Fourth, the use of conventional wires was not prohibited. This occurred in two cases. In one case, a Filterwire Ex wire (Boston Scientific, Natick, MA, USA) was deployed in one saphenous vein graft (SVG) case after the magnetic wire had been successfully passed and the restored flow showed a lesion in which distal protection was felt to be necessary. In a second case, the magnetic wire failed to enter a sidebranch so a conventional wire was tried but also failed to cross. However, flow improved and the result was accepted.
With regard to the performance of the rigid magnetic wire tip, no traumatic problems were seen with forward passage as the shaft behind the magnetic tip buckles similar to a conventional wire. However, in principle this rigidity could be an issue in sharply angulated turns that are narrow and constrained, and it is known that MPCI requires extra attention in order to avoid such problems as magnetic wire lock. 19 This comparison included procedures performed from 3 months after system acquisition (as a previous publication 5 suggested a learning curve) and was performed with the normal emergency team (that is two nursing staff in addition to the attending physician). The data in this comparison support the premise that, when the procedure is performed by experienced staff, there is no additional time delay but rather could lead to an advantage. In this study, even at this early stage in its development, the use of MPCI appears as safe, feasible, and successful as CPCI.
Study limitations
This comparison has the limitations associated with comparing a registry with historical controls and the lack of randomization. There were differences in the performance of the procedures. Only two of five CPCI operators performed MPCI and, although all five operators are experienced operators, and there was proportionately more experience in the CPCI group, operator bias cannot be excluded. The patients and the performing physicians Comparison of magnetically navigated and conventional PCI in acute MI
were not blinded to the type of procedure. The inclusion of the two groups was slightly different as inclusion in the magnetic procedure group depended on the presence of an operator and the availability of the magnetic room, whereas the PASSION study patients were performed by all operators. The target lesion characteristics were also slightly different. The PASSION study included those patients in whom the wire had successfully crossed the lesion and may have led to exclusion of more complex anatomy such as SVGs, stent thrombosis, or in-stent restenosis, whereas the MPCI group included all patients irrespective of stent thrombosis (five patients) or the presence of SVGs. In addition, MPCI was generally performed in smaller vessels (reference diameter 2.8 vs. 3.1 mm, P , 0.0001), the occurrence of hypertension was higher (40.2 vs. 32.3%, P ¼ 0.05) and the occurrence of previous CABG was higher (4.6 vs. 0.9%, P ¼ 0.03) compared with CPCI. However, these data suggest that more favourable patients were in the CPCI group, and had there been an equal distribution of these variables the results might have been further in favour of MPCI.
Conclusion
Primary PCI using the MNS appears feasible and does not negatively influence use of contrast media or irradiation. This is coupled with potential advantages such as reduction of wire entwinement. In addition, the option of 3D reconstruction remains available if complex anatomy is uncovered. This comparison suggests the feasibility and non-inferiority of the MNS in performing primary PCI and could aid the complex procedures sometimes needed in this emergent situation. Randomized controlled trials are warranted in order to further investigate the use of MPCI in this population.
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